comparemela.com

Latest Breaking News On - Zentalis pharmaceuticals stock - Page 1 : comparemela.com

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Releases Quarterly Earnings Results, Beats Estimates By $0.91 EPS

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Releases Quarterly Earnings Results, Beats Estimates By $0.91 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Melissab-epperly
Zentalis-pharmaceuticals
Zentalis-pharmaceuticals-stock
News-ratings-for-zentalis-pharmaceuticals-daily
Zentalis-pharmaceuticals-inc
Earnings-history-for-zentalis-pharmaceuticals
Zentalis-pharmaceuticals-company-profile
Get-free-report
Zentalis-pharmaceuticals-daily

Analysts Set Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Target Price at $38.57

Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven ratings firms that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average […]

China
Melissab-epperly
Securities-exchange-commission
Exchange-traded-concepts
Zentalis-pharmaceuticals-stock
China-universal-asset-management-co
Quest-partners
Nasdaq
News-ratings-for-zentalis-pharmaceuticals-daily
Zentalis-pharmaceuticals-inc
Analyst-recommendations-for-zentalis-pharmaceuticals

Kennedy Capital Management LLC Has $3.14 Million Stock Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)

Kennedy Capital Management LLC boosted its position in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) by 2.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 156,475 shares of the company’s stock after purchasing an additional 4,178 shares during the […]

Melissab-epperly
Quarter-for-zentalis-pharmaceuticals
Zentalis-pharmaceuticals-stock
Zentalis-pharmaceuticals
Ameritas-investment-partners-inc
Nasdaq
Zentalis-pharmaceuticals-inc
Principal-financial-group-inc
Zentalis-pharmaceuticals-company-profile
Exchange-commission
Insider-activity-at-zentalis-pharmaceuticals

Analysts Set Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) PT at $47.10

Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have earned an average recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued ratings on the stock in […]

Stifel-nicolaus
Analyst-recommendations-for-zentalis-pharmaceuticals
Zentalis-pharmaceuticals
Zentalis-pharmaceuticals-company-profile
Zentalis-pharmaceuticals-stock
Blackrock-inc
Securities-exchange-commission
News-ratings-for-zentalis-pharmaceuticals-daily
Zentalis-pharmaceuticals-inc
Nasdaq
Wells-fargo-company

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Shares Gap Down After Earnings Miss

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Shares Gap Down After Earnings Miss
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus
Jump-financial
Zentalis-pharmaceuticals-stock
Nasdaq
Opaleye-management-inc
Zentalis-pharmaceuticals-inc
News-ratings-for-zentalis-pharmaceuticals-daily
Securities-exchange-commission
Wells-fargo-company
Zentalis-pharmaceuticals
Hermes-inc

vimarsana © 2020. All Rights Reserved.